DS

Daniela Schalko

Director DIN 10927117
DIN 10927117 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Daniela Schalko

Data last updated:

Daniela Schalko was an Additional Director at Recipharm Lifesciences India Private Limited (from 2025) and Additional Director at Recipharm Holding India Private Limited (from 2025).

DIN 10927117
First Appointment 28 Jan 2025
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director28 Jan 20252017₹3 Lakh (FY 2024)Amalgamated
Additional Director28 Jan 20252016₹437 Cr (FY 2024)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Recipharm Lifesciences India Private Limited
Recipharm Holding India Private Limited
Premium access

Shareholding and investment profile for Daniela Schalko

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daniela Schalko

Daniela Schalko was first appointed on 28 Jan 2025 as Additional Director at Recipharm Lifesciences India Private Limited.

Daniela Schalko held 2 earlier board appointments: Recipharm Lifesciences India Private Limited (Additional Director, from 28 Jan 2025); Recipharm Holding India Private Limited (Additional Director, from 28 Jan 2025).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available